Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVETIRACETAM Cause Product dose omission? 202 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 202 reports of Product dose omission have been filed in association with LEVETIRACETAM (Levetiracetam). This represents 0.3% of all adverse event reports for LEVETIRACETAM.

202
Reports of Product dose omission with LEVETIRACETAM
0.3%
of all LEVETIRACETAM reports
9
Deaths
96
Hospitalizations

How Dangerous Is Product dose omission From LEVETIRACETAM?

Of the 202 reports, 9 (4.5%) resulted in death, 96 (47.5%) required hospitalization, and 7 (3.5%) were considered life-threatening.

Is Product dose omission Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVETIRACETAM. However, 202 reports have been filed with the FAERS database.

What Other Side Effects Does LEVETIRACETAM Cause?

Seizure (9,961) Drug ineffective (8,666) Off label use (5,789) Maternal exposure during pregnancy (3,197) Foetal exposure during pregnancy (2,604) Epilepsy (2,546) Generalised tonic-clonic seizure (2,276) Somnolence (2,070) Fatigue (1,972) Status epilepticus (1,883)

What Other Drugs Cause Product dose omission?

APREMILAST (4,567) DUPILUMAB (2,729) ALBUTEROL (1,742) USTEKINUMAB (1,653) INSULIN GLARGINE (1,500) ETANERCEPT (1,400) LENALIDOMIDE (1,400) RUXOLITINIB (1,376) ALIROCUMAB (1,354) DIMETHYL (1,248)

Which LEVETIRACETAM Alternatives Have Lower Product dose omission Risk?

LEVETIRACETAM vs LEVOBUNOLOL LEVETIRACETAM vs LEVOBUPIVACAINE LEVETIRACETAM vs LEVOCARNITINE LEVETIRACETAM vs LEVOCETIRIZINE LEVETIRACETAM vs LEVODOPA

Related Pages

LEVETIRACETAM Full Profile All Product dose omission Reports All Drugs Causing Product dose omission LEVETIRACETAM Demographics